TREATING VIRAL INFECTIONS HAVING VIRAL RNAs TRANSLATED BY A NON-IRES MEDIATED MECHANISM
AssigneeThe UAB Research Foundation
InventorSunnie R. Thompson
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe UAB Research Foundation
InventorSunnie R. Thompson
Estimating the term…
Provided herein are methods for preventing or treating a viral infection in a subject, wherein the viral infection is mediated by a virus comprising one or more viral RNA molecules translated by a ribosomal shunting mechanism or a non-IRES mediated mechanism. The methods comprise administering to a subject an agent that reduces ribosomal protein (Rps25) expression or function. Also provided are methods of inhibiting or promoting ribosomal shunting-mediated translation or non-IRES mediated translation. Also provided are methods of screening for an agent that inhibits or promotes ribosomal shunting-mediated translation or non-IRES mediated translation.
A method of treating or preventing a viral infection in a subject, the method comprising:
2-10. (canceled)
-32. (canceled)
A method of inhibiting ribosomal shunting-mediated translation or non-IRES mediated translation, the method comprising:
-42. (canceled)
A method of screening for an agent that inhibits or promotes ribosomal shunting-mediated translation or non-IRES mediated translation, the method comprising:
(canceled)
A method of identifying cellular RNA molecules translated by a ribosomal shunting mechanism or a non-IRES mediated mechanism, the method comprising:
A method of promoting ribosomal shunting-mediated translation or non-IRES mediated translation, the method comprising:
A method of promoting ribosomal shunting-mediated translation or non-IRES mediated translation, the method comprising providing a cell with a nucleic acid encoding a Rps25 protein or functional fragment thereof.
Dependencies are inferred from the claim text.